SlideShare a Scribd company logo
PRESENTATION BY-
Chandrashekhar Jain
M. Pharma 1st sem
CONTENTS
 QUALITY ASSURENCE
 USFDA
 WHO GUDLINE
 ISO 9000 SERIES
QUALITY ASSURENCE
Introduction
 Quality assurance is wide ranging concept covering all
matters that individually or collectively influence the
quality of a product
 It is the totality of the arrengement made with the object
of ensuring that pharmaceutical products are of the quality
required for their intended use.
Definition
 Quality assurance is heart and soul of quality control
 QA = QC+ GMP
 Quality assurance is the sum total of the organized
arrangement with the objective of ensuring that product
will be of the quality required for their intended use
Necessity
 It is necessary for production of drug / drug formulation
with desired quality
 It is important to provide drug dosage form with improved
and better quality
 To avoid toxic effect of formulation and to remove toxic
impurities
 For pre and post marketing quality control and for good
manufacturing practice
USFDA
Introduction
 The various guideline given by united state food and drug
administration are
 for the maintenance and for conducting the toxicological
studies
Bioequivalence studies
Clinical trial and
In the field of radiology
Product regulated by FDA
 Food
 Drugs
 Medical devices
 Biologics
 Animal food and drugs
 Cosmetics
 Radiation emitting products
 Combination product
Guidelines for
 Manufacturing of sterile product ( critical area & controlled
area)
 Guideline for radiological health – MRI
 Maintenance of storage temprature condition during transport
 Food, seafood and perishables
 Guideline for clinical trials
 Phase I clinical pharmacology trial
 Phase II exploratory trials
 Phase III confirmatory trial
 Phase IV
Protocol
REGULATORY
PROGRAMMES
Safety regulation varies by-
Type of product
Potential risk
Regulatory process
Regulates through set of published standards included with
facility inspections.
Inspection form 483.
FDA INSPECTION
 Vaccines and drug manufacturers.
 Blood banks
 Food processing facilities(diary farms)
 Facilities in clinical trials
 Labs that conduct studies on animals or microorganisms
includes approval of medical products
 Foreign manufacturing and processing sites for FDA
regulated product and imported products.
Contd..
Types of inspection-
I. PRE-APPROVAL INSPECTION
II. ROUTINE INSPECTION
III. FOR-CAUSE INSPECTION
 In electronic reading room inspection records are made
available to public request .
FORMS COMMONLY USED IN FDA
INSPECTIONS1. FDA FORM 482- Notice of inspection
2. FDA form 483- Inspectional observations
3. FDA form 484- Receipt for physical
evidence(eg.samples),but not for documentary
evidence(eg.label, copy).
RECALL?
 Product is removed from the market or correction is
made,
 Company can recall its products on its own
 company recalls a product if FDA raises concern.
Three types of recall classes-
i. CLASS 1
ii. CLASS 2
iii. CLASS 3
CFR TITLE 21
 Reserved for rules of the Food and Drug Administration.
 Received from Government Printing Office.
 PART 1 To 1499
 50 Titles Chapter Parts Sections
Paragraph
WHO GUIDELINE
Introduction
 World health organization is united nation
organization for health policy and for control over
health products and their quality
RESPONSIBILTY
Global Health Matters
Shaping the Health research agenda (schedule)
Setting norms & standards Articulating evidence based
policy option
Providing technical support to countries
Monitoring & assessing health trends
ORGANISATION
The Executive Board is composed of 32 members,
technically qualified in the field of health.
Members are elected for three years .
The head is the Director-General who is appointed by the
Health Assembly on the nomination of the Executive Board.
WHO Member States are grouped into six regions . Each region
has a regional office .
Regional offices are in Africa, America, South-east Asia, Europe,
Eastern Mediterranean & Western Pacific.
The World Health Assembly is the supreme decision-making
body for WHO.
It meets each year in May at Geneva , and is attended by
delegations from all 192 Member States .
FUNCTIONS
To give worldwide guidance in the field of health.
To set global standards for health.
To cooperate with governments in strengthening national
health programs.
To develop and transfer appropriate health technology
information.
WHO Expert Committee
Is an official Advisory Body to Director-General of
WHO Governed though specific rules and procedures.
Participation in Expert Committee (EC) meetings:
Members ("Expert") selected from WHO Panel of
Experts Technical advisers Observers : - international
organizations , - NGOs , - professional associations
Report of the WHO Expert Committee:
Summarizes discussion Gives recommendations to
WHO and Member States Also includes newly adopted
guidelines And is presented to WHO Governing Bodies
for final comments, endorsement and implementation
by Member States
WHO Expert Committee on Specifications for
Pharmaceutical Preparations
WHO Expert Committee on the Selection and Use of
Essential Medicines WHO Expert Committee on Drug
Dependence
WHO Expert Committee on Biological Standardization
Joint FAO/WHO Expert Committee on Food Additives
WHO Expert Committee (EC) meeting if guideline adopted,
published in EC report as Annex Recommendation to Member States
for implementation WHO consultation process working
Step 1. Preliminary consultation and drafting
Step 2. Draft guidelines Step
3. Circulation for comments
Step 4. Revision process .......... (back to step 2 and 3 as often as
needed)
 WHO guidelines:
 WHO guidelines Covers guidelines for
 Stability guidelines
 Sampling guidelines
 Production Quality Control Distribution
WHO stability guidelines
Title: “ guidelines for stability testing of pharmaceutical products
containing well established drug substances in conventional
dosage forms ”
It is for stability testing of final drug products -> those are well
established (e.g. generics) & -> in conventional dosage forms
(e.g. tablets)
Design of stability study includes guidelines for: -> test samples -
> test conditions - accelerated studies - real time studies -
>frequency of testing & evaluation of test results
WHO guidelines on sampling of pharmaceuticals
Contains :
Purpose of sampling Controls to be applied to the sample
Sampling operations and precautions Storage and retension
Sampling for regulatory purposes
Sampling plans for starting materials, packaging materials
and finished products
WHO’s guidelines for production Good Manufacturing Practices
(GMP)
1. Main principles for pharmaceutical products
2. for starting materials, including active pharmaceutical ingredients
pharmaceutical excipients
3. for specific pharmaceutical products: Sterile pharmaceutical products
Biological products Investigational pharmaceutical products for
clinical trials in humans Herbal medicines Radiopharmaceuticals
additional GMP texts:
1. Main principles for pharmaceutical products
requirement for the sampling of starting materials
(amendment)
2. water for pharmaceutical use heating, ventilation and
air-conditioning (HVAC) systems Validation
3. for specific pharmaceutical products: Herbal medicines
WHO’s guidelines for distribution
WHO Certification Scheme for Products Moving in International
Commerce
New scheme for pharmaceutical starting materials: - model certificate,
when inspected by national authority WHO model for self-assessment
for manufacture of pharmaceutical starting materials
Good Distribution and Trading Practices for pharmaceutical starting
materials (GTDP) Good Distribution Practices (GDP) (for products)
Good Storage Practices (GSP)
ISO 9000 SERIES
Introduction
 The ISO 9000 family addresses various aspects of quality
management and contains some of ISO’s best known
standards. The standards provide guidance and tools for
companies and organizations who want to ensure that their
products and services consistently meet customer’s
requirements, and that quality is consistently improved.
Background
© 2002 Systex Services 38
MIL Std
US Military & NATO Standards
AQAP
National Standards
BS
5750
CANADA
FRANCE
GERMANY
SPAIN
JAPAN
USA
UK
+ others
International Standards Organisation
(ISO) Committee
ISO
9000:
1987
International
Standard
ISO
9000:
1994
ISO
9000:
2000
What is ISO 9000? [1]
 ISO 9000 is an internationally recognised quality
management system developed by ISO (International
Organisation for Standardisation)
© 2002 Systex Services 39
UNIVERSALLY RECOGNISED - SOUND QUALITY SYSTEM
What Is ISO 9000? [2]
 ISO 9000 Series
© 2002 Systex Services 40
ISO 9000 : 2000
QUALITY MANAGEMENT SYSTEMS - Fundamentals and vocabulary
- supersedes ISO 8402 and ISO 9000-1:1994
ISO 9001: 2000
QUALITY MANAGEMENT SYSTEMS - Requirements
- supersedes ISO 9001/2/3:1994
ISO 19011: 2002
Guidelines on auditing quality and environmental management systems
- supersedes ISO 19011:1994
ISO 9004 : 2000
QUALITY MANAGEMENT SYSTEMS - Guidelines for improvement
- supersedes ISO 9004-1
What Is ISO 9000? [3]
 Standard based on 8 quality management
principles
 customer focus
 leadership
 involvement of people
 process approach
 system approach to management
 continual improvement
 factual approach to decision making
 mutually beneficial supplier relationships
© 2002 Systex Services 41
Process approach model
© 2002 Systex Services 42
CONTINUAL IMPROVEMENT OF
QUALITY MANAGEMENT SYSTEM
Product
realisation
Input
Product
Output
Measurement
analysis
improvement
Resource
management
Management
responsibility
ISO 9001 Requirements
4. Quality management system
5. Management responsibility
6. Resource management
7. Product realisation
8. Measurement, analysis and improvement
© 2002 Systex Services 43
Quality management system
 General requirements
 identify QMS processes
 sequence & interaction of processes
 criteria & measures for effective operation
 information to support processes
 measure, monitor, analyse, action & improvement
 General documentation requirements
 procedures
 other documents
© 2002 Systex Services 44
Management responsibility
 Management
commitment
 Customer focus
 Quality policy
 Planning
 quality objectives
 quality planning
 permissible exclusions
 resources
 continual improvement
 Administration
 responsibility & authority
 management represeantative
 internal communication
 quality manual
 control of documents
 control of quality records
 Management review
 inputs (results)
 outputs (actions / resources)
© 2002 Systex Services 45
Resource management
 Provision of resources
 relating to QMS
 customer satisfaction
 Human resources
 competency
 training
 effectiveness of training
 contribution to quality
objectives
 staff records
 Facilities
 workspace & facilities
 equipment, h/ware,
s/ware
 Work environment
 human & physical
factors
© 2002 Systex Services 46
Product realisation
 Planning of realisation
processes
 Customer related processes
 Design & development
 planning
 inputs
 outputs
 review
 verification
 validation
 changes
 Purchasing
 control
 information
 verification
 Production & service
operations
 control
 identification & traceability
 customer property
 preservation
 measuring & monitoring
© 2002 Systex Services 47
Measurement, analysis
& improvement
 Planning
 Measurement & monitoring
 customer satisfaction
 internal audit
 processes
 product
 control of noncomformity
 analysis of data
© 2002 Systex Services 48
Continued --->
Measurement, analysis
& improvement (continued)
 Improvement
 planning for continual
improvement
 corrective action
 identifying non-conform.
 causes
 solutions
 action
 results
 review
 preventive action
 potential non-
conformance
 preventive actions
 results of actions
 review
© 2002 Systex Services 49
Certification Milestones
© 2002 Systex Services 50
2. Prepare quality manual, policy, processes, planning
3. Prepare procedures, work instructions & records
10. Certification
9. External assessmentISO 9000
Certificate
Proced
-ures
Work
Instructs
Quality
Records
1. Brief management team
4. Implement procedures
5. Train internal auditors
6. Conduct internal audits
7. Conduct management review
8. Preliminary assessment
Quality
Policy
Quality
Manual
QMS
Processes
Quality
Plan
Who requires ISO 9000?
 Credible suppliers
 Major customers
 Government agencies
 Retailers
© 2002 Systex Services 51
NO LONGER A FEATURE - INCREASINGLY AN EXPECTATION
What Are The Benefits?
 Sound quality system
 Single systems audit
 Eligibility for tenders
 Evidence of compliance
 Recognition of standard achieved
 Opportunity to improve existing processes
 A process for continual improvement
© 2002 Systex Services 52
ADDED VALUE, MARKET
ACCESS & PRIDE
How long will it take?
 It has been done in less than 6 months…
 It has taken longer than 18 months…
 It can normally be done COMFORTABLY within 12 months
53
Responsibilities
 Management representative - for overall project & process control
 Prime & support - to develop & implement each ISO 9000 section
© 2002 Systex Services 54
# Section Prime Support
4 Quality management system
4.1 General requirements
4.2 General documentation requirements
5 Management responsibility
5.1 Management commitment
5.2 Customer focus
5.3 Quality policy
5.4 Planning
5.5 Administration
5.6 Management review
6 Resource management
6.1 Provision of resources
6.2 Human resources
6.3 Work environment
7 Product realisation
7.1 Planning realisation process
7.2 Customer related processes
7.3 Design and or development
7.4 Purchasing
7.5 Production and service operations
7.6 Control of measuring & monitoring devices
8 Measurement, analysis & improvement
8.1 Planning
8.2 Measurement & monitoring
8.3 Control of nonconformity
8.4 Analysis of data
8.5 Improvement
Schedule - short term
© 2002 Systex Services 55
LUNCH
DOCUMENT
PREPARATION
REVIEW & ACTION
PLANNING
LUNCHLUNCH LUNCH
PRESENTATIONS,
QUESTIONS &
ASSIGNMENTS
PLANT TOUR
CONSULTING
DAY 1 DAY 2 DAY 3 DAY 4
TOUR TEAM SOLOGROUP
0830
1000
1100
1230
1330
1430
1530
1700
0830
0930
1130
1230
1330
1500
1600
1700
4. QUALITY
MANAGEMENT
SYSTEMS
5. MANAGEMENT
RESPONSIBILITY
7.1 REALISATION
PROCESS
7.2 CUSTOMER
RELATED
PROCESSES
7.3 DESIGN
AND OR
DEVELOPMENT
7.4 PURCHASING
7.5 PRODUCTION
& SERVICE
OPERATIONS
7.6 CONTROL OF
MEASURING &
MONITORING
DEVICES
8.2 MEASURING
& MONITORING
8.3 CONTROL OF
NONCONFORMITY
8.4 ANALYSIS
OF DATA
8.5 IMPROVEMENT
Usfda, who guidline and iso 9000 series

More Related Content

What's hot

ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
02AishwaryaV
 
Qms Out of Specifications (oos)
Qms Out of Specifications (oos)Qms Out of Specifications (oos)
Qms Out of Specifications (oos)
Dr Ajay Kumar Tiwari
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation'
Sanathoiba Singha
 
Quality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical productQuality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical product
Prof. Dr. Basavaraj Nanjwade
 
Validation utility system
Validation utility systemValidation utility system
Validation utility system
ArpitSuralkar
 
ICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra MohanICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra Mohan
Chandra Mohan
 
Validation qualification
Validation qualificationValidation qualification
Validation qualification
Devipriya Viswambharan
 
General methods for analysis of food carbohydrates
General methods for analysis of food carbohydratesGeneral methods for analysis of food carbohydrates
General methods for analysis of food carbohydrates
Dr Raj kumar Kudari
 
Finished products presentation 2 2
Finished products presentation 2 2Finished products presentation 2 2
Finished products presentation 2 2
shaik malangsha
 
Stability zones and ich guideline q5c
Stability zones and ich guideline q5cStability zones and ich guideline q5c
Stability zones and ich guideline q5c
Kshitiz Kumar Gaund
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packaging
Jalal Uddin
 
Qualification of Analytical Equipments
Qualification of Analytical EquipmentsQualification of Analytical Equipments
Qualification of Analytical Equipments
Dhawal_Raghuvanshi
 
Q6 guidelines
Q6 guidelinesQ6 guidelines
Q6 guidelines
Anjali Aji
 
Container and closure for pharmaceutical
Container and closure for pharmaceuticalContainer and closure for pharmaceutical
Container and closure for pharmaceutical
Ashvin Bhoge
 
Developing specifications q3 q6
Developing specifications  q3 q6Developing specifications  q3 q6
Developing specifications q3 q6
NamrataBawaskar
 
Line clearance ppt
Line clearance pptLine clearance ppt
Line clearance ppt
Mumbai University
 
QA Role in Pharmaceutical Industry
QA Role in Pharmaceutical IndustryQA Role in Pharmaceutical Industry
QA Role in Pharmaceutical Industry
Yosef Andreas
 
paharmaceutical packaging Medical device Packaging types of medical device p...
paharmaceutical packaging Medical device Packaging  types of medical device p...paharmaceutical packaging Medical device Packaging  types of medical device p...
paharmaceutical packaging Medical device Packaging types of medical device p...
RavichandraNadagouda
 
Stability Testing During Product Development
Stability Testing During Product DevelopmentStability Testing During Product Development
Stability Testing During Product Development
Al Riyad Hasan
 

What's hot (20)

ICH Q10 guideline.pptx
ICH Q10 guideline.pptxICH Q10 guideline.pptx
ICH Q10 guideline.pptx
 
Docmentation complete
Docmentation completeDocmentation complete
Docmentation complete
 
Qms Out of Specifications (oos)
Qms Out of Specifications (oos)Qms Out of Specifications (oos)
Qms Out of Specifications (oos)
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation'
 
Quality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical productQuality assurance and regulatory compliance for pharmaceutical product
Quality assurance and regulatory compliance for pharmaceutical product
 
Validation utility system
Validation utility systemValidation utility system
Validation utility system
 
ICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra MohanICH Q6A Specifications by Chandra Mohan
ICH Q6A Specifications by Chandra Mohan
 
Validation qualification
Validation qualificationValidation qualification
Validation qualification
 
General methods for analysis of food carbohydrates
General methods for analysis of food carbohydratesGeneral methods for analysis of food carbohydrates
General methods for analysis of food carbohydrates
 
Finished products presentation 2 2
Finished products presentation 2 2Finished products presentation 2 2
Finished products presentation 2 2
 
Stability zones and ich guideline q5c
Stability zones and ich guideline q5cStability zones and ich guideline q5c
Stability zones and ich guideline q5c
 
Pharmaceutical packaging
Pharmaceutical packagingPharmaceutical packaging
Pharmaceutical packaging
 
Qualification of Analytical Equipments
Qualification of Analytical EquipmentsQualification of Analytical Equipments
Qualification of Analytical Equipments
 
Q6 guidelines
Q6 guidelinesQ6 guidelines
Q6 guidelines
 
Container and closure for pharmaceutical
Container and closure for pharmaceuticalContainer and closure for pharmaceutical
Container and closure for pharmaceutical
 
Developing specifications q3 q6
Developing specifications  q3 q6Developing specifications  q3 q6
Developing specifications q3 q6
 
Line clearance ppt
Line clearance pptLine clearance ppt
Line clearance ppt
 
QA Role in Pharmaceutical Industry
QA Role in Pharmaceutical IndustryQA Role in Pharmaceutical Industry
QA Role in Pharmaceutical Industry
 
paharmaceutical packaging Medical device Packaging types of medical device p...
paharmaceutical packaging Medical device Packaging  types of medical device p...paharmaceutical packaging Medical device Packaging  types of medical device p...
paharmaceutical packaging Medical device Packaging types of medical device p...
 
Stability Testing During Product Development
Stability Testing During Product DevelopmentStability Testing During Product Development
Stability Testing During Product Development
 

Similar to Usfda, who guidline and iso 9000 series

Good manufacturing and validation
Good manufacturing and validation Good manufacturing and validation
Good manufacturing and validation
IshwarJadhav4
 
Pharmaceuticals Quality management .pdf
Pharmaceuticals Quality management .pdfPharmaceuticals Quality management .pdf
Pharmaceuticals Quality management .pdf
UVAS
 
ICH GUIDELINE Q 23024671010_RA.pptx
ICH GUIDELINE Q      23024671010_RA.pptxICH GUIDELINE Q      23024671010_RA.pptx
ICH GUIDELINE Q 23024671010_RA.pptx
70KRISHPATEL
 
Approch to pharmaceutical certification
Approch to pharmaceutical certificationApproch to pharmaceutical certification
Approch to pharmaceutical certification
Diwakar Chudal
 
guias de amostragem.pdf
guias de amostragem.pdfguias de amostragem.pdf
guias de amostragem.pdf
AlexandreReinas1
 
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHOCác chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Harmonization,GMPs and validation
Harmonization,GMPs and validationHarmonization,GMPs and validation
Harmonization,GMPs and validation
Payal Ware
 
1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt
ssuser868fa0
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
Akshay Patil
 
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
sureshsamineni1
 
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
yashdhewal
 
Quality Control and Quality Assurance in Pharmaceuticals.pptx
Quality Control and Quality Assurance in Pharmaceuticals.pptxQuality Control and Quality Assurance in Pharmaceuticals.pptx
Quality Control and Quality Assurance in Pharmaceuticals.pptx
ShraddhaJadhav80
 
QA &QC.pdf
QA &QC.pdfQA &QC.pdf
QA &QC.pdf
Ruturajjadhav19
 
Who gmp compliance ppt
Who gmp compliance pptWho gmp compliance ppt
Who gmp compliance ppt
shrikant Deshmukh
 
ICH GUIDELINES.pptx
ICH GUIDELINES.pptxICH GUIDELINES.pptx
ICH GUIDELINES.pptx
AbdulNaim14
 
PHARMACEUTICAL ANALYSIS I.pdf
PHARMACEUTICAL ANALYSIS I.pdfPHARMACEUTICAL ANALYSIS I.pdf
PHARMACEUTICAL ANALYSIS I.pdf
AbdiIsaq1
 
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
QA_Pharmaceuticals-Vol2_1.pdf
QA_Pharmaceuticals-Vol2_1.pdfQA_Pharmaceuticals-Vol2_1.pdf
QA_Pharmaceuticals-Vol2_1.pdf
AjaySharma144859
 
ICH Guidelines with details of ICH Q3 Guidelines
ICH Guidelines with details of ICH Q3 GuidelinesICH Guidelines with details of ICH Q3 Guidelines
ICH Guidelines with details of ICH Q3 Guidelines
Prabhjot kaur
 
Quality Management System including the Quality management and certification
Quality Management System including the Quality management and certificationQuality Management System including the Quality management and certification
Quality Management System including the Quality management and certification
AshwiniRaikar1
 

Similar to Usfda, who guidline and iso 9000 series (20)

Good manufacturing and validation
Good manufacturing and validation Good manufacturing and validation
Good manufacturing and validation
 
Pharmaceuticals Quality management .pdf
Pharmaceuticals Quality management .pdfPharmaceuticals Quality management .pdf
Pharmaceuticals Quality management .pdf
 
ICH GUIDELINE Q 23024671010_RA.pptx
ICH GUIDELINE Q      23024671010_RA.pptxICH GUIDELINE Q      23024671010_RA.pptx
ICH GUIDELINE Q 23024671010_RA.pptx
 
Approch to pharmaceutical certification
Approch to pharmaceutical certificationApproch to pharmaceutical certification
Approch to pharmaceutical certification
 
guias de amostragem.pdf
guias de amostragem.pdfguias de amostragem.pdf
guias de amostragem.pdf
 
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHOCác chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
Các chỉ tiêu chính trong bộ tiêu chuẩn GMP WHO
 
Harmonization,GMPs and validation
Harmonization,GMPs and validationHarmonization,GMPs and validation
Harmonization,GMPs and validation
 
1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt1978237935_WHOGMP_ICH.ppt
1978237935_WHOGMP_ICH.ppt
 
cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]cmc [ chemistry manufacturing control ]
cmc [ chemistry manufacturing control ]
 
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
2.RecentAdvancements_IndianDrugRegulationsDraft_ScheduleM.pdf
 
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
PPT - CDSCO Recent Advancements_IndianDrugRegulations Draft_ScheduleM RUBINA ...
 
Quality Control and Quality Assurance in Pharmaceuticals.pptx
Quality Control and Quality Assurance in Pharmaceuticals.pptxQuality Control and Quality Assurance in Pharmaceuticals.pptx
Quality Control and Quality Assurance in Pharmaceuticals.pptx
 
QA &QC.pdf
QA &QC.pdfQA &QC.pdf
QA &QC.pdf
 
Who gmp compliance ppt
Who gmp compliance pptWho gmp compliance ppt
Who gmp compliance ppt
 
ICH GUIDELINES.pptx
ICH GUIDELINES.pptxICH GUIDELINES.pptx
ICH GUIDELINES.pptx
 
PHARMACEUTICAL ANALYSIS I.pdf
PHARMACEUTICAL ANALYSIS I.pdfPHARMACEUTICAL ANALYSIS I.pdf
PHARMACEUTICAL ANALYSIS I.pdf
 
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
Ủy ban chuyên gia WHO về thông số kỹ thuật trong sản xuất dược phẩm
 
QA_Pharmaceuticals-Vol2_1.pdf
QA_Pharmaceuticals-Vol2_1.pdfQA_Pharmaceuticals-Vol2_1.pdf
QA_Pharmaceuticals-Vol2_1.pdf
 
ICH Guidelines with details of ICH Q3 Guidelines
ICH Guidelines with details of ICH Q3 GuidelinesICH Guidelines with details of ICH Q3 Guidelines
ICH Guidelines with details of ICH Q3 Guidelines
 
Quality Management System including the Quality management and certification
Quality Management System including the Quality management and certificationQuality Management System including the Quality management and certification
Quality Management System including the Quality management and certification
 

Recently uploaded

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
Vikramjit Singh
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 

Recently uploaded (20)

Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Digital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and ResearchDigital Tools and AI for Teaching Learning and Research
Digital Tools and AI for Teaching Learning and Research
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 

Usfda, who guidline and iso 9000 series

  • 2. CONTENTS  QUALITY ASSURENCE  USFDA  WHO GUDLINE  ISO 9000 SERIES
  • 4. Introduction  Quality assurance is wide ranging concept covering all matters that individually or collectively influence the quality of a product  It is the totality of the arrengement made with the object of ensuring that pharmaceutical products are of the quality required for their intended use.
  • 5. Definition  Quality assurance is heart and soul of quality control  QA = QC+ GMP  Quality assurance is the sum total of the organized arrangement with the objective of ensuring that product will be of the quality required for their intended use
  • 6. Necessity  It is necessary for production of drug / drug formulation with desired quality  It is important to provide drug dosage form with improved and better quality  To avoid toxic effect of formulation and to remove toxic impurities  For pre and post marketing quality control and for good manufacturing practice
  • 8. Introduction  The various guideline given by united state food and drug administration are  for the maintenance and for conducting the toxicological studies Bioequivalence studies Clinical trial and In the field of radiology
  • 9. Product regulated by FDA  Food  Drugs  Medical devices  Biologics  Animal food and drugs  Cosmetics  Radiation emitting products  Combination product
  • 10. Guidelines for  Manufacturing of sterile product ( critical area & controlled area)  Guideline for radiological health – MRI  Maintenance of storage temprature condition during transport  Food, seafood and perishables  Guideline for clinical trials  Phase I clinical pharmacology trial  Phase II exploratory trials  Phase III confirmatory trial  Phase IV Protocol
  • 11. REGULATORY PROGRAMMES Safety regulation varies by- Type of product Potential risk Regulatory process Regulates through set of published standards included with facility inspections. Inspection form 483.
  • 12. FDA INSPECTION  Vaccines and drug manufacturers.  Blood banks  Food processing facilities(diary farms)  Facilities in clinical trials  Labs that conduct studies on animals or microorganisms includes approval of medical products  Foreign manufacturing and processing sites for FDA regulated product and imported products.
  • 13. Contd.. Types of inspection- I. PRE-APPROVAL INSPECTION II. ROUTINE INSPECTION III. FOR-CAUSE INSPECTION  In electronic reading room inspection records are made available to public request .
  • 14.
  • 15.
  • 16.
  • 17. FORMS COMMONLY USED IN FDA INSPECTIONS1. FDA FORM 482- Notice of inspection 2. FDA form 483- Inspectional observations 3. FDA form 484- Receipt for physical evidence(eg.samples),but not for documentary evidence(eg.label, copy).
  • 18. RECALL?  Product is removed from the market or correction is made,  Company can recall its products on its own  company recalls a product if FDA raises concern. Three types of recall classes- i. CLASS 1 ii. CLASS 2 iii. CLASS 3
  • 19. CFR TITLE 21  Reserved for rules of the Food and Drug Administration.  Received from Government Printing Office.  PART 1 To 1499  50 Titles Chapter Parts Sections Paragraph
  • 21. Introduction  World health organization is united nation organization for health policy and for control over health products and their quality
  • 22. RESPONSIBILTY Global Health Matters Shaping the Health research agenda (schedule) Setting norms & standards Articulating evidence based policy option Providing technical support to countries Monitoring & assessing health trends
  • 23. ORGANISATION The Executive Board is composed of 32 members, technically qualified in the field of health. Members are elected for three years . The head is the Director-General who is appointed by the Health Assembly on the nomination of the Executive Board.
  • 24. WHO Member States are grouped into six regions . Each region has a regional office . Regional offices are in Africa, America, South-east Asia, Europe, Eastern Mediterranean & Western Pacific. The World Health Assembly is the supreme decision-making body for WHO. It meets each year in May at Geneva , and is attended by delegations from all 192 Member States .
  • 25. FUNCTIONS To give worldwide guidance in the field of health. To set global standards for health. To cooperate with governments in strengthening national health programs. To develop and transfer appropriate health technology information.
  • 26. WHO Expert Committee Is an official Advisory Body to Director-General of WHO Governed though specific rules and procedures. Participation in Expert Committee (EC) meetings: Members ("Expert") selected from WHO Panel of Experts Technical advisers Observers : - international organizations , - NGOs , - professional associations
  • 27. Report of the WHO Expert Committee: Summarizes discussion Gives recommendations to WHO and Member States Also includes newly adopted guidelines And is presented to WHO Governing Bodies for final comments, endorsement and implementation by Member States
  • 28. WHO Expert Committee on Specifications for Pharmaceutical Preparations WHO Expert Committee on the Selection and Use of Essential Medicines WHO Expert Committee on Drug Dependence WHO Expert Committee on Biological Standardization Joint FAO/WHO Expert Committee on Food Additives
  • 29. WHO Expert Committee (EC) meeting if guideline adopted, published in EC report as Annex Recommendation to Member States for implementation WHO consultation process working Step 1. Preliminary consultation and drafting Step 2. Draft guidelines Step 3. Circulation for comments Step 4. Revision process .......... (back to step 2 and 3 as often as needed)
  • 30.  WHO guidelines:  WHO guidelines Covers guidelines for  Stability guidelines  Sampling guidelines  Production Quality Control Distribution
  • 31. WHO stability guidelines Title: “ guidelines for stability testing of pharmaceutical products containing well established drug substances in conventional dosage forms ” It is for stability testing of final drug products -> those are well established (e.g. generics) & -> in conventional dosage forms (e.g. tablets) Design of stability study includes guidelines for: -> test samples - > test conditions - accelerated studies - real time studies - >frequency of testing & evaluation of test results
  • 32. WHO guidelines on sampling of pharmaceuticals Contains : Purpose of sampling Controls to be applied to the sample Sampling operations and precautions Storage and retension Sampling for regulatory purposes Sampling plans for starting materials, packaging materials and finished products
  • 33. WHO’s guidelines for production Good Manufacturing Practices (GMP) 1. Main principles for pharmaceutical products 2. for starting materials, including active pharmaceutical ingredients pharmaceutical excipients 3. for specific pharmaceutical products: Sterile pharmaceutical products Biological products Investigational pharmaceutical products for clinical trials in humans Herbal medicines Radiopharmaceuticals
  • 34. additional GMP texts: 1. Main principles for pharmaceutical products requirement for the sampling of starting materials (amendment) 2. water for pharmaceutical use heating, ventilation and air-conditioning (HVAC) systems Validation 3. for specific pharmaceutical products: Herbal medicines
  • 35. WHO’s guidelines for distribution WHO Certification Scheme for Products Moving in International Commerce New scheme for pharmaceutical starting materials: - model certificate, when inspected by national authority WHO model for self-assessment for manufacture of pharmaceutical starting materials Good Distribution and Trading Practices for pharmaceutical starting materials (GTDP) Good Distribution Practices (GDP) (for products) Good Storage Practices (GSP)
  • 37. Introduction  The ISO 9000 family addresses various aspects of quality management and contains some of ISO’s best known standards. The standards provide guidance and tools for companies and organizations who want to ensure that their products and services consistently meet customer’s requirements, and that quality is consistently improved.
  • 38. Background © 2002 Systex Services 38 MIL Std US Military & NATO Standards AQAP National Standards BS 5750 CANADA FRANCE GERMANY SPAIN JAPAN USA UK + others International Standards Organisation (ISO) Committee ISO 9000: 1987 International Standard ISO 9000: 1994 ISO 9000: 2000
  • 39. What is ISO 9000? [1]  ISO 9000 is an internationally recognised quality management system developed by ISO (International Organisation for Standardisation) © 2002 Systex Services 39 UNIVERSALLY RECOGNISED - SOUND QUALITY SYSTEM
  • 40. What Is ISO 9000? [2]  ISO 9000 Series © 2002 Systex Services 40 ISO 9000 : 2000 QUALITY MANAGEMENT SYSTEMS - Fundamentals and vocabulary - supersedes ISO 8402 and ISO 9000-1:1994 ISO 9001: 2000 QUALITY MANAGEMENT SYSTEMS - Requirements - supersedes ISO 9001/2/3:1994 ISO 19011: 2002 Guidelines on auditing quality and environmental management systems - supersedes ISO 19011:1994 ISO 9004 : 2000 QUALITY MANAGEMENT SYSTEMS - Guidelines for improvement - supersedes ISO 9004-1
  • 41. What Is ISO 9000? [3]  Standard based on 8 quality management principles  customer focus  leadership  involvement of people  process approach  system approach to management  continual improvement  factual approach to decision making  mutually beneficial supplier relationships © 2002 Systex Services 41
  • 42. Process approach model © 2002 Systex Services 42 CONTINUAL IMPROVEMENT OF QUALITY MANAGEMENT SYSTEM Product realisation Input Product Output Measurement analysis improvement Resource management Management responsibility
  • 43. ISO 9001 Requirements 4. Quality management system 5. Management responsibility 6. Resource management 7. Product realisation 8. Measurement, analysis and improvement © 2002 Systex Services 43
  • 44. Quality management system  General requirements  identify QMS processes  sequence & interaction of processes  criteria & measures for effective operation  information to support processes  measure, monitor, analyse, action & improvement  General documentation requirements  procedures  other documents © 2002 Systex Services 44
  • 45. Management responsibility  Management commitment  Customer focus  Quality policy  Planning  quality objectives  quality planning  permissible exclusions  resources  continual improvement  Administration  responsibility & authority  management represeantative  internal communication  quality manual  control of documents  control of quality records  Management review  inputs (results)  outputs (actions / resources) © 2002 Systex Services 45
  • 46. Resource management  Provision of resources  relating to QMS  customer satisfaction  Human resources  competency  training  effectiveness of training  contribution to quality objectives  staff records  Facilities  workspace & facilities  equipment, h/ware, s/ware  Work environment  human & physical factors © 2002 Systex Services 46
  • 47. Product realisation  Planning of realisation processes  Customer related processes  Design & development  planning  inputs  outputs  review  verification  validation  changes  Purchasing  control  information  verification  Production & service operations  control  identification & traceability  customer property  preservation  measuring & monitoring © 2002 Systex Services 47
  • 48. Measurement, analysis & improvement  Planning  Measurement & monitoring  customer satisfaction  internal audit  processes  product  control of noncomformity  analysis of data © 2002 Systex Services 48 Continued --->
  • 49. Measurement, analysis & improvement (continued)  Improvement  planning for continual improvement  corrective action  identifying non-conform.  causes  solutions  action  results  review  preventive action  potential non- conformance  preventive actions  results of actions  review © 2002 Systex Services 49
  • 50. Certification Milestones © 2002 Systex Services 50 2. Prepare quality manual, policy, processes, planning 3. Prepare procedures, work instructions & records 10. Certification 9. External assessmentISO 9000 Certificate Proced -ures Work Instructs Quality Records 1. Brief management team 4. Implement procedures 5. Train internal auditors 6. Conduct internal audits 7. Conduct management review 8. Preliminary assessment Quality Policy Quality Manual QMS Processes Quality Plan
  • 51. Who requires ISO 9000?  Credible suppliers  Major customers  Government agencies  Retailers © 2002 Systex Services 51 NO LONGER A FEATURE - INCREASINGLY AN EXPECTATION
  • 52. What Are The Benefits?  Sound quality system  Single systems audit  Eligibility for tenders  Evidence of compliance  Recognition of standard achieved  Opportunity to improve existing processes  A process for continual improvement © 2002 Systex Services 52 ADDED VALUE, MARKET ACCESS & PRIDE
  • 53. How long will it take?  It has been done in less than 6 months…  It has taken longer than 18 months…  It can normally be done COMFORTABLY within 12 months 53
  • 54. Responsibilities  Management representative - for overall project & process control  Prime & support - to develop & implement each ISO 9000 section © 2002 Systex Services 54 # Section Prime Support 4 Quality management system 4.1 General requirements 4.2 General documentation requirements 5 Management responsibility 5.1 Management commitment 5.2 Customer focus 5.3 Quality policy 5.4 Planning 5.5 Administration 5.6 Management review 6 Resource management 6.1 Provision of resources 6.2 Human resources 6.3 Work environment 7 Product realisation 7.1 Planning realisation process 7.2 Customer related processes 7.3 Design and or development 7.4 Purchasing 7.5 Production and service operations 7.6 Control of measuring & monitoring devices 8 Measurement, analysis & improvement 8.1 Planning 8.2 Measurement & monitoring 8.3 Control of nonconformity 8.4 Analysis of data 8.5 Improvement
  • 55. Schedule - short term © 2002 Systex Services 55 LUNCH DOCUMENT PREPARATION REVIEW & ACTION PLANNING LUNCHLUNCH LUNCH PRESENTATIONS, QUESTIONS & ASSIGNMENTS PLANT TOUR CONSULTING DAY 1 DAY 2 DAY 3 DAY 4 TOUR TEAM SOLOGROUP 0830 1000 1100 1230 1330 1430 1530 1700 0830 0930 1130 1230 1330 1500 1600 1700 4. QUALITY MANAGEMENT SYSTEMS 5. MANAGEMENT RESPONSIBILITY 7.1 REALISATION PROCESS 7.2 CUSTOMER RELATED PROCESSES 7.3 DESIGN AND OR DEVELOPMENT 7.4 PURCHASING 7.5 PRODUCTION & SERVICE OPERATIONS 7.6 CONTROL OF MEASURING & MONITORING DEVICES 8.2 MEASURING & MONITORING 8.3 CONTROL OF NONCONFORMITY 8.4 ANALYSIS OF DATA 8.5 IMPROVEMENT